WHO ICTRP trial
Effects of Omega-3 fatty acids for psychotic disorders
JPRN-jRCTs041190054 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs041190054 |
|---|---|
| Public title | Effects of Omega-3 fatty acids for psychotic disorders |
| Scientific title | Effects of Omega-3 fatty acids for schizophrenia and at-risk mental state |
| Primary sponsor | Higuchi Yuko |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Schizophrenia, at-risk mental state (ARMS) schizophrenia;schizophrenia |
| Interventions | One-year administration of omega-3 polyunsaturated fatty acids |
| Registration date | Jul 22, 2019 |
| Target size | 134 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: